Efficacy and Safety of Sofosbuvir and Ribavirin in Treatment of Chronic Hepatitis C Infection G3 of Multi-Transfused Children Aged 4 To 12 Years; A Single Center Study . mfm. 2023;34(7). Accessed December 27, 2025. https://medicalforummonthly.com/index.php/mfm/article/view/4409